Skip to content

BIOCODEX Benelux

Active
Public limited companyfounded 1960active for 66 yearsHumaniteitslaan 292, 1190 Vorst, Belgium24 active companies are registered at this addressKBO/BCE: BE 0401.936.623
Summary

BIOCODEX Benelux has been active since 1960 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €517,335. Equity is growing by about 13% per year across the filed financial years. Its solvency ranks better than 16% of 6,141 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
3rd oldest company in Vorst, Wholesale and retail trade sector1 site
Size
€20.0mturnover 2025
Staff
49.9 FTE
Equity
€1.1m
Profit
€517,335
Financial health
88 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Parent
Biocodex S.A.
Auditor: CDP PETIT & CO2025 accounts 66 days early1 of 21 deeds summarised
Why 88raises riskEquity €1.1m (13.9% of total assets)lowers riskFounded in 1960Profit of €517,335 (financial year 2025)Liquidity: current ratio 0.97, cash €1.5mShow the evidence

Checked score

Score 2025
88 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 37% of its sector peers (NACE 46, small)
Financial strength · tick = 2024
Weak
Solvency 39+5
equity 13.9% of total assets
Liquidity 25-8
short-term debt 85.4% · cash 17.9%
Profitability 49-11
return on assets 6.4%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (4,373 companies, NACE 46, small)
Last 24 months 11-2024: 0.4%highest value 12-2024: 0.4%● unchanged vs 11-2024highest value 01-2025: 0.4%● unchanged vs 12-2024highest value 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.2%▼ -0.2 percentage points vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025lowest value 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €95,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.97, compared with 0.91 in 2024, below 1; short-term debt: 85.4% and cash: 17.9% of total assets), and 86.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, small): better than 15% on solvency, 23% on liquidity, 33% on profitability and 76% on growth.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Equity €1.1m (13.9% of total assets)
NBB · annual accounts
lowers risk · Founded in 1960
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Profit of €517,335 (financial year 2025)
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.97, cash €1.5m
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 6141 sector peers (2025).
NBB · sector comparison
Position among 6141 sector peers
Solvency
better than 16%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-05-2026, 66 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
66 days early
2024
59 days early
2023
64 days early
2022
77 days early
2021
76 days early
2020
64 days early
2019
70 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 68 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 May (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
26-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Equity above €1mequity €1.1m ▲48.3%
  3. Annual accounts filedfinancial year 2024 · full…

Key points

  • Positive: Result rose in 2025from €170,129 to €517,335 ▲ 204% View
  • Positive: 3rd oldest company in Vorst, Wholesale and retail trade sectorin the Checked rankings No. 3 View
  • Positive: 5 years of growth in a rowturnover 2025: €20.0m 5 years View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Controlled by Biocodex S.A. parent View
  • Active since 1960founded 26-02-1960 66 years View

By topic

Financials

Financial year
2025
Turnover
€20.0m
Profit
€517,335
Solvency
13.9%
Turnover▲ 3.3%
Net result
20182025
Go to Financials

Board & ownership

Board
3 members
Parent
Biocodex S.A.
Auditor
CDP PETIT & CO
  • BIOCODEXDirector
  • François HublotManaging director
  • Jean-Marie LefevreDirector
Go to Board & ownership

Timeline

Events
56
Since
1978
Next accounts
by 31-07-2027
  1. 28-05-2024Annual accounts filed
  2. 02-01-2024Reappointments: François Hublot, Jean-Marie Lefevre and 2…
  3. 31-12-2023Highest result from 2018 to 2025
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
26-02-1960
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about BIOCODEX Benelux

What is the company number of BIOCODEX Benelux?
0401.936.623. In Belgium the VAT number is the company number with BE in front: BE 0401.936.623.
Where is BIOCODEX Benelux based?
The registered office is at Humaniteitslaan 292, 1190 Vorst.Company details
What does BIOCODEX Benelux do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of BIOCODEX Benelux?
Public limited company (NV).
When was BIOCODEX Benelux founded?
On 26-02-1960.
Is BIOCODEX Benelux still active?
Yes, BIOCODEX Benelux is an active enterprise in the KBO register.
How many employees does BIOCODEX Benelux have?
On average 49.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of BIOCODEX Benelux?
€20.0m in financial year 2025, according to the filed annual accounts.
Is BIOCODEX Benelux profitable?
In financial year 2025, BIOCODEX Benelux made a profit of €517,335.
Where can I find the annual accounts of BIOCODEX Benelux?
BIOCODEX Benelux filed 49 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BIOCODEX Benelux due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to BIOCODEX Benelux

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.